Genotypic resistance profiles in Chinese patients with chronic hepatitis B virus infection and the efficacy of nucleoside analog rescue therapy

Ling-Bo LiangCenter of Infectious Disease, State Key Laboratory of Biotherapy, West China Hospital, West China School of Medicine, Sichuan University, Chengdu, People’s Republic of China

Lan-Lan ChenCenter of Infectious Disease, State Key Laboratory of Biotherapy, West China Hospital, West China School of Medicine, Sichuan University, Chengdu, People’s Republic of China

En-Qiang ChenCenter of Infectious Disease, State Key Laboratory of Biotherapy, West China Hospital, West China School of Medicine, Sichuan University, Chengdu, People’s Republic of China

Juan LiaoCenter of Infectious Disease, State Key Laboratory of Biotherapy, West China Hospital, West China School of Medicine, Sichuan University, Chengdu, People’s Republic of China

Hong TangCenter of Infectious Disease, State Key Laboratory of Biotherapy, West China Hospital, West China School of Medicine, Sichuan University, Chengdu, People’s Republic of ChinaCorrespondence[email protected]

Pages 417-423 | Published online: 12 Mar 2015

Cite this article
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

References

PawlotskyJMDusheikoGHatzakisAVirologic monitoring of hepatitis B virus therapy in clinical trials and practice: recommendations for a standardized approachGastroenterology2008134240541518242209
PubMed Web of Science ®Google Scholar
DienstagJLHepatitis B virus infectionN Engl J Med2008359141486150018832247
PubMed Web of Science ®Google Scholar
ZoulimFPerrilloRHepatitis B: reflections on the current approach to antiviral therapyJ Hepatol200848Suppl 1S2S1918304680
PubMed Web of Science ®Google Scholar
LaiCLDienstagJSchiffEPrevalence and clinical correlates of YMDD variants during lamivudine therapy for patients with chronic hepatitis BClin Infect Dis200336668769612627352
PubMed Web of Science ®Google Scholar
LokASLaiCLLeungNLong-term safety of lamivudine treatment in patients with chronic hepatitis BGastroenterology200312561714172214724824
PubMed Web of Science ®Google Scholar
ZoulimFLocarniniSHepatitis B virus resistance to nucleos(t)ide analoguesGastroenterology200913751593160819737565
PubMed Web of Science ®Google Scholar
HadziyannisSJTassopoulosNCHeathcoteEJAdefovir Dipivoxil 438 Study GroupLong-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B for up to 5 yearsGastroenterology200613161743175117087951
PubMed Web of Science ®Google Scholar
MarcellinPChangTTLimSGLong-term efficacy and safety of adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis BHepatology200848375075818752330
PubMed Web of Science ®Google Scholar
LiawYFGaneELeungNGLOBE Study Group2-Year GLOBE trial results: telbivudine is superior to lamivudine in patients with chronic hepatitis BGastroenterology2009136248649519027013
PubMed Web of Science ®Google Scholar
LokASMcMahonBJChronic hepatitis B: update 2009Hepatology200950366166219714720
PubMed Web of Science ®Google Scholar
HadziyannisSJTassopoulosNCHeathcoteEJAdefovir Dipivoxil 438 Study GroupAdefovir dipivoxil for the treatment of hepatitis B e antigen-negative chronic hepatitis BN Engl J Med2003348980080712606734
PubMed Web of Science ®Google Scholar
ChangTTGishRGde ManRBEHoLD AI463022 Study GroupA comparison of entecavir and lamivudine for HBeAg-positive chronic hepatitis BN Engl J Med2006354101001101016525137
PubMed Web of Science ®Google Scholar
LaiCLShouvalDLokASBEHoLD AI463027 Study GroupEntecavir versus lamivudine for patients with HBeAg-negative chronic hepatitis BN Engl J Med2006354101011102016525138
PubMed Web of Science ®Google Scholar
LaiCLGaneELiawYFGlobe Study GroupTelbivudine versus lamivudine in patients with chronic hepatitis BN Engl J Med2007357252576258818094378
PubMed Web of Science ®Google Scholar
MarcellinPHeathcoteEJButiMTenofovir disoproxil fumarate versus adefovir dipivoxil for chronic hepatitis BN Engl J Med2008359232442245519052126
PubMed Web of Science ®Google Scholar
ChonYEParkJYAhnSHPartial virological response to adefovir add-on lamivudine rescue therapy in patients with lamivudine-resistant chronic hepatitis BDigestion201387319620323689059
PubMed Web of Science ®Google Scholar
KwonDHKimIHChoungBSContinuous long-term entecavir therapy in naïve chronic hepatitis B patients showing partial virologic responseGut Liver20137671271824312713
PubMed Web of Science ®Google Scholar
SalpiniRAlteriCCentoVSnapshot on drug-resistance rate and profiles in patients with chronic hepatitis B receiving nucleos(t)ide analogues in clinical practiceJ Med Virol2013856996100423588725
PubMed Web of Science ®Google Scholar
European Association For The Study Of The LiverEASL clinical practice guidelines: management of chronic hepatitis B virus infectionJ Hepatol201257116718522436845
PubMed Web of Science ®Google Scholar
HongthanakornCChotiyaputtaWOberhelmanKVirological breakthrough and resistance in patients with chronic hepatitis B receiving nucleos(t)ide analogues in clinical practiceHepatology20115361854186321618260
PubMed Web of Science ®Google Scholar
GhanyMGDooECAntiviral resistance and hepatitis B therapyHepatology2009495 SupplS174S18419399794
PubMed Web of Science ®Google Scholar
MutimerDPillayDCookPSelection of multiresistant hepatitis B virus during sequential nucleoside-analogue therapyJ Infect Dis2000181271371610669360
PubMed Web of Science ®Google Scholar
KimSSChoSWKimSOHongSPCheongJYMultidrug-resistant hepatitis B virus resulting from sequential monotherapy with lamivudine, adefovir, and entecavir: clonal evolution during lamivudine plus adefovir therapyJ Med Virol2013851556423096938
PubMed Web of Science ®Google Scholar
LiuCJKaoJHGlobal perspective on the natural history of chronic hepatitis B: role of hepatitis B virus genotypes A to JSemin Liver Dis20133329710223749665
PubMed Web of Science ®Google Scholar
HsiehTHTsengTCLiuCJHepatitis B virus genotype B has an earlier emergence of lamivudine resistance than genotype CAntivir Ther20091481157116320032545
PubMed Web of Science ®Google Scholar

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Genotypic resistance profiles in Chinese patients with chronic hepatitis B virus infection and the efficacy of nucleoside analog rescue therapy

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Genotypic resistance profiles in Chinese patients with chronic hepatitis B virus infection and the efficacy of nucleoside analog rescue therapy

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date